The DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
Open accessAbstract
The pathogenesis of type 2 diabetes involves abnormalities in insulin action, insulin secretion, and endogenous glucose output (EGO). However, the sequence with which these abnormalities develop and their relative contributions to the deterioration in glucose tolerance remain unclear in the absence of a detailed longitudinal study. We measured insulin action, insulin secretion, and EGO longitudinally in 17 Pima Indians, in whom glucose tolerance deteriorated from normal (NGT) to impaired (IGT) to diabetic over 5.1 +/- 1.4 years. Transition from NGT to IGT was associated with an increase in body weight, a decline in insulin-stimulated glucose disposal, and a decline in the acute insulin secretory response (AIR) to intravenous glucose, but no change in EGO. Progression from IGT to diabetes was accompanied by a further increase in body weight, further decreases in insulin-stimulated glucose disposal and AIR, and an increase in basal EGO. Thirty-one subjects who retained NGT over a similar period also gained weight, but their AIR increased with decreasing insulin-stimulated glucose disposal. Thus, defects in insulin secretion and insulin action occur early in the pathogenesis of diabetes. Intervention to prevent diabetes should target both abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Insulin resistance and concurrent relative insulin deficiency and glucagon dysregulation underlie T2D pathophysiology.33–35”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [34]
Experimental — accuracy not yet measuredIn the citing paper
“These findings derived from cross-sectional data are supported by a longitudinal study in Pima Indians that has also shown the importance of accounting for the hyperbolic relationship between insulin sensitivity and insulin secretion and demonstrated the presence of impaired beta-cell function in those destined to progress to Type 2 diabetes [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Seventeen (35%) of these subjects progressed from NGT to IGT and then to diabetes during follow up.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Our finding of a hyperbolic relationship between insulin sensitivity and insulin secretion in healthy subjects has been confirmed in large cohorts of Danish [94] and Pima Indian subjects [95].”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“During follow up, insulin secretion declined progressively by 78% while insulin sensitivity decreased by only 14%.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Based on the UKPDS [18] and the longitudinal assessment in Pima Indians [95], the major reason for the decline in glucose tolerance seems to be a progressive loss of beta-cell function.”
From The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes (2003) · cites this paper as [95]
In the citing paper
“Further progressive deterioration of β-cell function accounts for the evolving natural history of the disease from impaired glucose tolerance to type 2 diabetes10,11.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [10]
In the citing paper
“Our results may help explain the aforementioned association between N3 lack and T2DM, as a loss in first-phase insulin secretion is both an early marker of T2DM and part of its pathogenesis (20).”
From Sleep architecture and glucose and insulin homeostasis in obese adolescents (2011) · cites this paper as [20]
In the citing paper
“IGT and T2DM ensue when beta cell function fails to compensate.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
In the citing paper
“Insulin resistance precedes the development of hyperglycemia and T2DM and results in compensatory hyperinsulinemia.”
From The Vasculature in Prediabetes (2018) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
National Diabetes Data Group (1979) · Diabetes · doi:10.2337/diab.28.12.1039 · Cited by 4,909
Immunoassay of endogenous plasma insulin in man
Yalow, R. S., & Berson, S. A. (1960) · Journal of Clinical Investigation · doi:10.1172/jci104130 · Cited by 3,041
Coated Charcoal Immunoassay of Insulin
Herbert, V. D., Lau, K., Gottlieb, C. W., & Bleicher, S. J. (1965) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-25-10-1375 · Cited by 2,969
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s5 · Cited by 2,689
Body composition from fluid spaces and density: analysis of methods. 1961.
Siri, W. E. (1994) · PubMed · Cited by 2,556
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Pathogenesis of NIDDM. A balanced overview.
DeFronzo, R. A., Bonadonna, R. C., & Ferrannini, E. (1992) · Diabetes Care · doi:10.2337/diacare.15.3.318 · Cited by 2,085
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 5×
“It is well known that there is a hyperbolic relationship between early insulin secretion and insulin action in individuals with NGT, meaning that, cross-sectionally, insulin secretion increases with decreasing insulin action and vice versa (51, 52).”
BackgroundMethodInfluentialTechniques for Measuring Body Composition
National Research Council (1961) · National Academies Press eBooks · doi:10.17226/21603 · Cited by 1,620
Flagged first, then by citations
1 of the 68 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- 1998, Diabetes Care, 21(Suppl. 1), S5
- DeFronzo, 1997, Diabetes Reviews, 5, 177
- Abbott, 1990, Am J Physiol, 258, E347
- Bogardus, 1984, J Clin Invest, 78, 1568
- Schwartz, 1995, J Clin Endocrinol Metab, 80, 1571
- Luzi, 1989, Am J Physiol, 257, E241
Cited by
Sorted by citations
Items 301–400 of 1,002
Klemen, M. S., Dolenšek, J., Rupnik, M. S., & Stožer, A. (2017) · Islets · doi:10.1080/19382014.2017.1342022 · Cited by 102
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
Kalyani, R. R. (2021) · New England Journal of Medicine · doi:10.1056/nejmcp2000280 · Cited by 101
Ustione, A., & Piston, D. W. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1226 · Cited by 101
Nrf2 and Redox Status in Prediabetic and Diabetic Patients
Jiménez‐Osorio, A. S., Picazo, A., González-Reyes, S., Barrera‐Oviedo, D., Rodríguez-Arellano, M. E., & Pedraza‐Chaverrí, J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120290 · Cited by 101
Xiang, A. H., Wang, C., Peters, R. K., Trigo, E., Kjos, S. L., & Buchanan, T. A. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1109 · Cited by 101
Glimerpiride in type 2 diabetes mellitus: A review of the worldwide therapeutic experience
Massi‐Benedetti, M. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80109-1 · Cited by 101
Sandforth, A., von Schwartzenberg, R. J., Arreola, E. V., Hanson, R. L., Sancar, G., Katzenstein, S., Lange, K., Preißl, H., Dreher, S. I., Weigert, C., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00235-8 · Cited by 100
Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance
Wei, Y., Wang, D., Topczewski, F., & Pagliassotti, M. J. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.03.013 · Cited by 100
D'Alessio, D. A., Denney, A. M., Hermiller, L. M., Prigeon, R. L., Martin, J. M., Tharp, W. G., Saylan, M. L., He, Y., Dunning, B. E., Foley, J. E., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1135 · Cited by 99
Self-citationCaliff, R. M., Boolell, M., Haffner, S. M., Bethel, M. A., McMurray, J. J. V., Duggal, A., & Holman, R. R. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.05.017 · Cited by 99
Rask, E., Olsson, T., Söderberg, S., Holst, J. J., Tura, A., Pacini, G., & Åhrén, B. (2004) · Metabolism · doi:10.1016/j.metabol.2003.11.011 · Cited by 99
The polymorphisms of UCP1 genes associated with fat metabolism, obesity and diabetes
Jia, J., Tian, Y., Cao, Z.-H., Tao, L., Zhang, X., Gao, S., Ge, C., Lin, Q., & Jois, M. (2009) · Molecular Biology Reports · doi:10.1007/s11033-009-9550-2 · Cited by 99
Persistence of Pre-Diabetes in Overweight and Obese Hispanic Children
Goran, M. I., Lane, C. J., Toledo‐Corral, C. M., & Weigensberg, M. J. (2008) · Diabetes · doi:10.2337/db08-0445 · Cited by 99
Kim-Muller, J. Y., Zhao, S., Srivastava, S., Mugabo, Y., Noh, H. L., Kim, Y., Madiraju, S. R. M., Ferrante, A. W., Skolnik, E. Y., Prentki, M., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.012 · Cited by 98
Handelsman, Y., Anderson, J. E., Bakris, G. L., Ballantyne, C. M., Bhatt, D. L., Bloomgarden, Z. T., Bozkurt, B., Budoff, M. J., Butler, J., Cherney, D. Z. I., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155931 · Cited by 99
Self-citationMinireview: Dopaminergic Regulation of Insulin Secretion from the Pancreatic Islet
Ustione, A., Piston, D. W., & Harris, P. E. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1083 · Cited by 98
Experimental IUGR and later diabetes
Martin‐Gronert, M. S., & Ozanne, S. E. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01800.x · Cited by 98
The role of insulin and the adipocytokines in regulation of vascular endothelial function
Ritchie, S. A., Ewart, M., Perry, C. G., Connell, J., & Salt, I. P. (2004) · Clinical Science · doi:10.1042/cs20040190 · Cited by 98
Weiss, S. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.19.2277 · Cited by 98
Kahn, S. E., Deanfield, J. E., Jeppesen, O. K., Emerson, S. S., Boesgaard, T. W., Colhoun, H. M., Kushner, R. F., Lingvay, I., Burguera, B. G., Gajos, G., et al. (2024) · Diabetes Care · doi:10.2337/dc24-0491 · Cited by 102
Sesti, G., Federici, M., Lauro, D., Sbraccia, P., & Lauro, R. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.225 · Cited by 96
Bromocriptine – unique formulation of a dopamine agonist for the treatment of type 2 diabetes
Scranton, R. E., & Cincotta, A. H. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903501544 · Cited by 96
Treatment of insulin resistance in diabetes mellitus
Lebovitz, H. E., & Banerji, M. A. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.051 · Cited by 96
Yabe, D., Nishikino, R., Kaneko, M., Iwasaki, M., & Seino, Y. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1034105 · Cited by 96
Classification and Diagnosis of Diabetes
GENUTH, S. M., Palmer, J. P., & Nathan, D. M. (2018) · Cited by 95
Calcium-activated Calpain-2 Is a Mediator of Beta Cell Dysfunction and Apoptosis in Type 2 Diabetes
Huang, C., Gurlo, T., Haataja, L., Costes, S., Daval, M., Ryazantsev, S., Wu, X., Butler, A. E., & Butler, P. C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.024190 · Cited by 96
Michaliszyn, S. F., Mari, A., Lee, S., Bacha, F. F., Tfayli, H. M., Farchoukh, L. O., Ferrannini, E., & Arslanian, S. A. (2014) · Diabetes · doi:10.2337/db13-1951 · Cited by 95
Schuster, D. P., & Duvuuri, V. (2002) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/s0891-8422(03)00082-x · Cited by 94
D’Alessandris, C., Andreozzi, F., Federici, M., Cardellini, M., Brunetti, A., Ranalli, M., Guerra, S. D., Lauro, D., Prato, S. D., Marchetti, P., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0725fje · Cited by 94
Genetic Variants at the Resistin Locus and Risk of Type 2 Diabetes in Caucasians
Ma, X., Warram, J. H., Trischitta, V., & Doria, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020109 · Cited by 94
Characterization of insulin secretion and resistance in type 2 diabetes of adolescents
Druet, C., Tubiana-Rufi, N., Chevenne, D., Rigal, O., Polak, M., & Levy-Marchal, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1672 · Cited by 93
Horton, W. B., Love, K. M., Gregory, J. M., Liu, Z., & Barrett, E. J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00826.2024 · Cited by 95
Incretin mimetics and DPP-IV inhibitors for the treatment of type 2 diabetes
Nielsen, L. L. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03460-4 · Cited by 93
Pajvani, U. B., & Accili, D. (2015) · Diabetologia · doi:10.1007/s00125-015-3722-5 · Cited by 92
The Effects of the Dietary Glycemic Load on Type 2 Diabetes Risk Factors during Weight Loss
Pittas, A. G., Roberts, S. B., Das, S. K., Gilhooly, C. H., Saltzman, E. J., Golden, J. K., Stark, P. C., & Greenberg, A. S. (2006) · Obesity · doi:10.1038/oby.2006.258 · Cited by 92
Are the available experimental models of type 2 diabetes appropriate for a gender perspective?
Franconi, F., Seghieri, G., Canu, S., Straface, E., Campesi, I., & Malorni, W. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.11.007 · Cited by 92
Alanine Aminotransferase and Directly Measured Insulin Sensitivity in a Multiethnic Cohort
Hanley, A. J., Wagenknecht, L. E., Festa, A., D'Agostino, R. B., & Haffner, S. M. (2007) · Diabetes Care · doi:10.2337/dc07-0086 · Cited by 92
Vischer, U. M., Safar, M. E., Safar, H., Iaria, P., Dudal, K. L., Henry, O., Herrmann, F. R., Ducimetière, P., & Blacher, J. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.08.006 · Cited by 92
Weyer, C., Hanson, K. A., Bogardus, C., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250050005 · Cited by 91
Self-citationEmerging treatments for post-transplantation diabetes mellitus
Jenssen, T., & Hartmann, A. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.59 · Cited by 90
In Vivo Insulin Sensitivity and Secretion in Obese Youth
Bacha, F., Gungor, N., Lee, S., & Arslanian, S. A. (2009) · Diabetes Care · doi:10.2337/dc08-1030 · Cited by 90
Ameliorative effect of myricetin on insulin resistance in mice fed a high-fat, high-sucrose diet
Choi, H., Kang, M., Lee, S., & Kim, J.-I. (2014) · Nutrition Research and Practice · doi:10.4162/nrp.2014.8.5.544 · Cited by 90
Conneely, K. N., Silander, K., Scott, L. J., Mohlke, K. L., Lazaridis, K. N., Valle, T. T., Tuomilehto, J., Bergman, R. N., Watanabe, R. M., Buchanan, T. A., et al. (2004) · Diabetologia · doi:10.1007/s00125-004-1537-x · Cited by 90
Actos Now for the prevention of diabetes (ACT NOW) study
DeFronzo, R. A., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S., Henry, R. R., Kitabchi, A. E., Mudaliar, S., Musi, N., Ratner, R., et al. (2009) · BMC Endocrine Disorders · doi:10.1186/1472-6823-9-17 · Cited by 89
Monnier, L., Colette, C., & Owens, D. R. (2009) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.962 · Cited by 89
Funakoshi, S., Fujimoto, S., Hamasaki, A., Fujiwara, H., Fujita, Y., Ikeda, K., Hamamoto, Y., Hosokawa, M., Seino, Y., & Inagaki, N. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.010 · Cited by 89
Assessment of insulin secretion in relation to insulin resistance
Mari, A., Åhrén, B., & Pacini, G. (2005) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000171130.23441.59 · Cited by 89
Federici, M., Hribal, M. L., Ranalli, M., Marselli, L., Porzio, O., Lauro, D., Borboni, P., Lauro, R., Marchetti, P., Melino, G., et al. (2000) · The FASEB Journal · doi:10.1096/fj.00-0414fje · Cited by 89
Kim, S. P., Catalano, K. J., Hsu, I. R., Chiu, J. D., Richey, J. M., & Bergman, R. N. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00669.2006 · Cited by 89
Potential role of skeletal muscle glucose metabolism on the regulation of insulin secretion
Mizgier, M. L., Casas, M., Contreras‐Ferrat, A. E., Llanos, P., & Galgani, J. E. (2014) · Obesity Reviews · doi:10.1111/obr.12166 · Cited by 88
Approach to the Patient with Prediabetes
Aroda, V. R., & Ratner, R. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1091 · Cited by 87
Agarwal, P., Srivastava, R., Srivastava, R., Ali, S., & Datta, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.021 · Cited by 88
Insulin Resistance and Impaired Insulin Secretion in Prenatally Androgenized Male Rhesus Monkeys
Bruns, C. M., Baum, S. T., Colman, R. J., Eisner, J. R., Kemnitz, J. W., Weindruch, R. H., & Abbott, D. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0918 · Cited by 87
Kanat, M., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i12.1207 · Cited by 87
Emerging role of testosterone in pancreatic β cell function and insulin secretion
Xu, W., Morford, J. J., & Mauvais‐Jarvis, F. (2019) · Journal of Endocrinology · doi:10.1530/joe-18-0573 · Cited by 86
Islet adaptation to insulin resistance: mechanisms and implications for intervention
Åhrén, B., & Pacini, G. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00361.x · Cited by 86
Effects of intermittent fasting on cognitive health and Alzheimer’s disease
Elias, A., Padinjakara, N., & Lautenschlager, N. T. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad021 · Cited by 85
Marion, V., Mockel, A., Melo, C. D., Obringer, C., Claussmann, A., Simon, A., Messaddeq, N., Durand, M., Dupuis, L., Loeffler, J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.08.005 · Cited by 85
Wagner, J. D., Cline, J. M., Shadoan, M. K., Bullock, B. C., Rankin, S. E., & Cefalu, W. T. (2001) · Toxicologic Pathology · doi:10.1080/019262301301418955 · Cited by 85
Jiang, Y., Owei, I., Wan, J. Y., Ebenibo, S., & Dagogo-Jack, S. E. (2016) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2016-000194 · Cited by 85
Rudovich, N. N., Rochlitz, H., & Pfeiffer, A. F. H. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2359 · Cited by 85
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance
Amato, M. C., Vesco, R., Vigneri, E., Ciresi, A., & Giordano, C. S. D. S. (2015) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0372-x · Cited by 84
Fat Mass Accumulation during Childhood Determines Insulin Sensitivity in Early Adulthood
Leunissen, R. W. J., Oosterbeek, P., Hol, L. K. M., Hellingman, A. A., Stijnen, T., & Hokken‐Koelega, A. C. S. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1543 · Cited by 84
Postchallenge Hyperglycemia in a National Sample of U.S. Adults With Type 2 Diabetes
Erlinger, T. P., & Brancati, F. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1734 · Cited by 83
Pathogenesis of Selective Insulin Resistance in Isolated Hepatocytes
Cook, J. R., Langlet, F., Kido, Y., & Accili, D. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638197 · Cited by 83
Nonhuman Primates and other Animal Models in Diabetes Research
Harwood, H. J., Listrani, P., & Wagner, J. D. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600304 · Cited by 83
Hanley, A. J., D’Agostino, R., Wagenknecht, L. E., Saad, M. F., Savage, P. J., Bergman, R. N., & Haffner, S. M. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1263 · Cited by 83
Evolution of Exenatide as a Diabetes Therapeutic
Bhavsar, S., Mudaliar, S. R. D., & Cherrington, A. D. (2013) · Current Diabetes Reviews · doi:10.2174/1573399811309020007 · Cited by 82
Bergenstal, R. M., Lewin, A. J., Bailey, T. S., Chang, D., Gylvin, T., Roberts, V. L., & for the NovoLog Mix-vs.-Exenatide Study Group (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802597951 · Cited by 82
Chronic Resveratrol Treatment Protects Pancreatic Islets against Oxidative Stress in db/db Mice
Lee, Y. E., Kim, J.-W., Lee, E. M., Ahn, Y., Song, K., Yoon, K., Kim, H.-W., Park, C.-W., Li, G., Liu, Z., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050412 · Cited by 82
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population
Zaghlool, S. B., Halama, A., Stephan, N., Guðmundsdóttir, V., Gudnason, V. G., Jennings, L. L., Thangam, M., Ahlqvist, E., Malik, R. A., Albagha, O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34754-z · Cited by 81
GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES
Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M. J., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2007-3-4-71-99 · Cited by 81
Discovery and Fine-Mapping of Glycaemic and Obesity-Related Trait Loci Using High-Density Imputation
Horikoshi, M., Mägi, R., van de Bunt, M., Surakka, I. L., Sarin, A., Mahajan, A., Marullo, L., Þorleifsson, G., Hägg, S., Hottenga, J., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005230 · Cited by 81
Uçak, S., Ekmekci, T., Basat, O., Koslu, A., & Altuntaş, Y. (2006) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2006.01499.x · Cited by 81
on behalf of the RISC Investigators, Ferrannini, E., Natali, A., Muscelli, E., Nilsson, P. M., Golay, A., Laakso, M., Beck-Nielsen, H., & Mari, A. (2011) · Diabetologia · doi:10.1007/s00125-011-2112-x · Cited by 80
Androgen Excess in Pancreatic β Cells and Neurons Predisposes Female Mice to Type 2 Diabetes
Navarro, G., Allard, C., Morford, J. J., Xu, W., Liu, S., Molinas, A. J. R., Butcher, S. M., Fine, N. H. F., Blandino-Rosano, M., Sure, V. N., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.98607 · Cited by 80
Udaya Rajesh, R., & Sangeetha, D. (2023) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2023.104881 · Cited by 81
Staiger, K., Stefan, N., Staiger, H., Brendel, M. D., Brandhorst, D., Bretzel, R. G., Machicao, F. E., Kellerer, M., Stümvoll, M., Fritsche, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0467 · Cited by 80
Castro, F. G., Shaibi, G. Q., & Boehm-Smith, E. (2008) · Journal of Behavioral Medicine · doi:10.1007/s10865-008-9194-z · Cited by 80
H elicobacter pylori infection associated with high H b A 1c and type 2 diabetes
Hsieh, M., Wang, S. S. W., Hsieh, Y., Kuo, F., Soon, M., & Wu, D. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12124 · Cited by 82
Clinical and Genetic Determinants of Progression of Type 2 Diabetes: A DIRECT Study
Zhou, K., Donnelly, L. A., Morris, A. D., Franks, P. W., Jennison, C., Palmer, C. N. A., & Pearson, E. R. (2013) · Diabetes Care · doi:10.2337/dc13-1995 · Cited by 80
Relationships Among Age, Proinsulin Conversion, and β-Cell Function in Nondiabetic Humans
Fritsche, A., Madaus, A., Stefan, N., Tschritter, O., Maerker, E., Teigeler, A., Häring, H. U., & Stümvoll, M. (2002) · Diabetes · doi:10.2337/diabetes.51.2007.s234 · Cited by 80
ß‐cell function and anti‐diabetic pharmacotherapy
Prato, S. D., Bianchi, C., & Marchetti, P. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.770 · Cited by 79
Tripathy, D., Carlsson, X. C. L., Lehto, M. J., Isomaa, B., Tuomi, T., & Groop, L. (2000) · Diabetologia · doi:10.1007/s001250051558 · Cited by 79
Semwal, D. K., Kumar, A., Aswal, S., Chauhan, A., & Semwal, R. B. (2020) · Phytotherapy Research · doi:10.1002/ptr.6885 · Cited by 78
Role of the SIK2–p35–PJA2 complex in pancreatic β-cell functional compensation
Sakamaki, J.-I., Fu, A., Reeks, C., Baird, S. D., Depatie, C., Azzabi, M. A., Bardeesy, N. M., Gingras, A., Yee, S., & Screaton, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb2919 · Cited by 78
Mechanisms of Impaired Fasting Glucose and Glucose Intolerance Induced by a ∼50% Pancreatectomy
Matveyenko, A. V., Veldhuis, J. D., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db06-0345 · Cited by 77
Irisin: A Multifaceted Hormone Bridging Exercise and Disease Pathophysiology
Paoletti, I., & Coccurello, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413480 · Cited by 81
Asghar, Z., Yau, D., Chan, F., LeRoith, D., Chan, C. B., & Wheeler, M. B. (2005) · Diabetologia · doi:10.1007/s00125-005-0045-y · Cited by 77
A gut–brain neural circuit controlled by intestinal gluconeogenesis is crucial in metabolic health
Soty, M., Penhoat, A., Amigó-Correig, M., Vinera, J., Sardella, A., Vulin-Bouilloux, F., Zitoun, C., Houberdon, I., & Mithieux, G. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.12.009 · Cited by 76
Authors Task Force Members, Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M., Cosentino, F., Jönsson, B., Laakso, M., et al. (2007) · European Heart Journal Supplements · doi:10.1093/eurheartj/ehl261 · Cited by 76
Incretins and other peptides in the treatment of diabetes
Todd, J. F., & Bloom, S. R. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.02071.x · Cited by 76
Tschritter, O., Stümvoll, M., Machicao, F. E., Holzwarth, M. G., Weisser, M., Maerker, E., Teigeler, A., Häring, H. U., & Fritsche, A. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2854 · Cited by 76
A link between hepatic glucose production and peripheral energy metabolism via hepatokines
Abdul-Wahed, A., Gautier‐Stein, A., Casteras, S., Soty, M., Roussel, D., Romestaing, C., Guillou, H., Tourette, J.-A., Plèche, N., Zitoun, C., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.05.005 · Cited by 75
van Genugten, R. E., van Raalte, D. H., & Diamant, M. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01473.x · Cited by 76
Blüher, M., Kratzsch, J., & Paschke, R. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.328 · Cited by 75
Tripathy, D., Eriksson, K. F., Orho-Melander, M., Fredriksson, J., Ahlqvist, G., & Groop, L. (2004) · Diabetologia · doi:10.1007/s00125-004-1393-8 · Cited by 74
Tripathy, D., Wessman, Y., Gullström, M., Tuomi, T., & Groop, L. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1395 · Cited by 74
Nanda, M., Sharma, R., Mubarik, S., Aashima, A., & Zhang, K. (2022) · Endocrine · doi:10.1007/s12020-022-03125-5 · Cited by 74
Wallander, M., Bartnik, M., Efendić, S., Hamsten, A., Malmberg, K., Öhrvik, J., Rydén, L., Silveira, A. M. V., & Norhammar, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1931-z · Cited by 74
Metadata
- Authors
- Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Weyer, Christian
- Venue
- Journal of Clinical Investigation
- Published
- 1999-09-15
- Volume
- 104
- Issue
- 6
- Pages
- 787-794
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408438
- OpenAlex
- W2077149049
- Cited by
- 1,940
- References
- 68
- Citations by year
- 2026: 24 · 2025: 53 · 2024: 53 · 2023: 74 · 2022: 63 · 2021: 80 · 2020: 64 · 2019: 64 · 2018: 61 · 2017: 72 · 2016: 88 · 2015: 81 · 2014: 91 · 2013: 85 · 2012: 83
- FWCI
- 44.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, impaired glucose tolerance, Pima Indians, insulin-stimulated glucose disposal, weight gain, diabetes prevention, pathogenesis
- MeSH terms
- Insulin Secretion, Adult, Anthropometry, Diabetes Mellitus, Type 2, Female, Glucose, Glucose Tolerance Test, Humans, Insulin, Insulin Resistance, Male, Obesity, Sex Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
